IL-5 in asthma

Chung, K. F.; van Rensen, E.; Stirling, R.; Barnes, P. J.
August 2002
Thorax;Aug2002, Vol. 57 Issue 8, p751
Academic Journal
Presents a letter to the editor on effects of interleukin-5 on asthma patients.


Related Articles

  • A novel dimer configuration revealed by the crystal structure at 2.4 angstrom resolution of human... Milburn, Michael V.; Hassell, Anne M. // Nature;5/13/1993, Vol. 363 Issue 6425, p172 

    Discusses the part interleukin-5 (IL-5), a lineage-specific cytokine for eosinophilpoiesis, plays in diseases associated with increased eosinophils, such as asthma. How the crystal structure of human IL-5 at 2.4 angstrom resolution reveals a novel two-domain structure; Characteristics of the...

  • Creation of a biologically active interleukin-5 monomer. Dickason, Richard R.; Huston, David P. // Nature;2/15/1996, Vol. 379 Issue 6566, p652 

    Determines that all of the structural features necessary for Interleukin-5 (IL-5) to function are contained within a single helical bundle.

  • Development of IL-5 Receptor Antagonists. Uings, Iain; McKinnon, Murray // Current Pharmaceutical Design;Sep2002, Vol. 8 Issue 20, p1837 

    A wealth of both clinical and pre-clinical data has strongly implicated the eosinophil in the pathogenesis of asthma, highlighting this cell type as a potential target for novel anti-inflammatory approaches to asthma therapy. The Th2 lymphocyte derived cytokine Interleukin-5 (IL-5) has emerged...

  • Increased Coexpression of Eotaxin and Interleukin 5 in Bullous Pemphigoid. Shrikhande, M.; Hunziker, T.; Braathen, L. R.; Pichler, W. J.; Dahinden, C. A.; Yawalkar, N. // Acta Dermato-Venereologica;09/20/2000, Vol. 80 Issue 4 

    While the presence of eosinophils in the skin lesions of bullous pemphigoid is well documented, the chemotactic factors responsible for eosinophil recruitment into the tissue still remain to be defined. In this study, eotaxin and interleukin-5 (IL-5) concentrations were determined in the blister...

  • The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the... Sayos, J.; Wu, C. // Nature;10/1/1998, Vol. 395 Issue 6701, p462 

    Shows that a T-cell specific, SLAM-associated protein (SAP) which contains a SH2 domain and a short tail, acts as an inhibitor by blocking recruitment of the SH2-domain-containing signal-transduction molecule. System used in determining proteins that interact with the cytoplasmic domain of...

  • Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice. Stevceva, L; Pavli, P; Husband, A; Matthaei, K I; Young, I G; Doe, W F // Genes & Immunity;Feb2000, Vol. 1 Issue 3, p213 

    Tissue eosinophilia is a feature of idiopathic inflammatory bowel disease and other forms of colonic inflammation but it is not clear whether the role of eosinophils in the disease process is to contribute to tissue damage. Interleukin 5 (IL-5) stimulates production and activation of eosinophils...

  • 2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome. Ueno, N T; Zhao, S; Robertson, L E; Consoli, U; Andreeff, M // Leukemia (08876924);Aug97, Vol. 11 Issue 8, p1386 

    Idiopathic hypereosinophilic syndrome (HES) is a rare disease with no established effective therapy. It has been reported that interleukin-5 (IL-5) produced by helper T cells plays a major role in the proliferation of eosinophils. The nucleotide analogue 2-chlorodeoxyadenosine (2-CdA), which...

  • The multi-organ origin of interleukin-5 in the mouse. Ryan, P J; Willson, T; Alexander, W S; Di Rago, L; Mifsud, S; Metcalf, D // Leukemia (08876924);Aug2001, Vol. 15 Issue 8, p1248 

    Murine Ba/F3 cells were transfected with cDNA for the 3-chain of the murine interleukin-5 (IL-5) receptor and cloned lines of these cells were able to proliferate in response to as little as 2.5 pg/ml of IL-5. The bioassay was demonstrated to be specific for IL-5 and was able to measure IL-5...

  • Interleukin-5, Eosinophilic Diseases and Therapeutic Intervention. Zabeau, Lennart; Gevaert, Philippe; Bachert, Claus; Tavernier, Jan // Current Drug Targets - Inflammation & Allergy;Dec2003, Vol. 2 Issue 4, p319 

    Interleukin 5 (IL-5) is the key cytokine in an eosinophil's life span: it supports eosinophilopoiesis and eosinophil differentiation, contributes to eosinophil migration, tissue localisation and function, and prevents eosinophil apoptosis. Given the likely role of eosinophils in chronic...


Read the Article


Sign out of this library

Other Topics